Clinical trials update from the European-Society of Cardiology: CARMEN, EARTH, OPTIMAAL, ACE, TEN-HMS, MAGIC, SOLVD-X and PATH-CHF II

被引：18

作者：

Coletta, AP ^{[1
]}

Louis, AA ^{[1
]}

Clark, AL ^{[1
]}

Nikitin, N ^{[1
]}

Cleland, JGF ^{[1
]}

机构：

[1] Univ Hull, Castle Hull Hosp, Dept Acad Cardiol, Kingston Upon Hull HU15 5JQ, Yorks, England

来源：

EUROPEAN JOURNAL OF HEART FAILURE | 2002年 / 4卷 / 05期

关键词：

heart failure; CARMEN; EARTH; OPTIMAAL; ACE; TEN-HMS; MAGIC; SOLVD-X; PATH-CHF II;

D O I：

10.1016/S1388-9842(02)00176-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This article continues a series of reports on research developments related to the field of heart failure. Reports of presentations made at the Hot Line sessions of the European Society of Cardiology XXIV Congress held in Berlin, Germany, between 31 August and 4 September 2002 are included. Summaries of the results of the following trials are presented: CARMEN, EARTH, OPTIMAAL, ACE, TEN-HMS, MAGIC, SOLVD-X and PATH-CHF II. (C) 2002 European Society of Cardiology. Published by Elsevier Science B.V. All rights reserved.

引用

页码：661 / 666

页数：6

共 17 条

[1] *ANT CARD US EN ST, 2002, Z KARDIOL, V91, P249
[2] Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
Brenner, BM
Cooper, ME
de Zeeuw, D
Keane, WF
Mitch, WE
Parving, HH
Remuzzi, G
Snapinn, SM
Zhang, ZX
Shahinfar, S
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) : 861 - 869
[3] *CARMEN STEER COMM, 2001, CARDIOVASC DRUG THER, V15, P69
[4] Clinical trials update: highlights of the scientific sessions of the American College of Cardiology 2002: LIFE, DANAMI 2, MADIT-2, MIRACLE-ICD, OVERTURE, OCTAVE, ENABLE 1 & 2, CHRISTMAS, AFFIRM, RACE, WIZARD, AZACS, REMATCH, BNP trial and HARDBALL
Coletta, A
Thackray, S
Nikitin, N
Cleland, JGF
[J]. EUROPEAN JOURNAL OF HEART FAILURE, 2002, 4 (03) : 381 - 388
[5] Clinical trials update: highlights of the scientific sessions of the XXIII Congress of the European Society of Cardiology - WARIS II, ESCAMI, PAFAC, RITZ-1 and TIME
Coletta, AP
Cleland, JGF
[J]. EUROPEAN JOURNAL OF HEART FAILURE, 2001, 3 (06) : 747 - 750
[6] Endothelin antagonists for chronic heart failure: do they have a role?
Cowburn, PJ
Cleland, JGF
[J]. EUROPEAN HEART JOURNAL, 2001, 22 (19) : 1772 - 1784
[7] Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol
Dahlöf, B
Devereux, RB
Kjeldsen, SE
Julius, S
Beevers, G
de Faire, U
Fyhrquist, F
Ibsen, H
Kristiansson, K
Lederballe-Pedersen, O
Lindholm, LH
Nieminen, MS
Omvik, P
Oparil, S
Wedel, H
[J]. LANCET, 2002, 359 (9311) : 995 - 1003
[8] Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAL randomised trial
Dickstein, K
Kjekshus, J
[J]. LANCET, 2002, 360 (9335) : 752 - 760
[9] Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction:: The OPTIMAAL trial design
Dickstein, K
Kjekshus, J
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1999, 83 (04) : 477 - 481
[10] EFFECTS OF LONG-TERM ENALAPRIL THERAPY ON CARDIAC STRUCTURE AND FUNCTION IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION - RESULTS OF THE SOLVD ECHOCARDIOGRAPHY SUBSTUDY
GREENBERG, B
QUINONES, MA
KOILPILLAI, C
LIMACHER, M
SHINDLER, D
BENEDICT, C
SHELTON, B
[J]. CIRCULATION, 1995, 91 (10) : 2573 - 2581

← 1 2 →